Voyageur Pharmaceuticals (CVE:VM) Trading 21.1% Higher – Time to Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) shares shot up 21.1% during trading on Friday . The stock traded as high as C$0.12 and last traded at C$0.12. 710,813 shares were traded during mid-day trading, an increase of 344% from the average session volume of 160,239 shares. The stock had previously closed at C$0.10.

Voyageur Pharmaceuticals Trading Up 36.8 %

The firm has a market cap of C$18.13 million, a price-to-earnings ratio of -13.00 and a beta of 0.32. The business has a fifty day moving average of C$0.07 and a two-hundred day moving average of C$0.06. The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Featured Stories

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.